Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Augmented anti-tumor activity of NK-92 cells expressing chimeric receptors of TGF-βR II and NKG2D
Zhongjuan Wang, Linghua Guo, Yuan Song, et al.
Cancer Immunology Immunotherapy (2017) Vol. 66, Iss. 4, pp. 537-548
Closed Access | Times Cited: 69

Showing 1-25 of 69 citing articles:

Chimeric Antigen Receptor Expressing Natural Killer Cells for the Immunotherapy of Cancer
Rohtesh S. Mehta, Katayoun Rezvani
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 235
Natural killer cell homing and trafficking in tissues and tumors: from biology to application
Guanghe Ran, Yu qing Lin, Lei Tian, et al.
Signal Transduction and Targeted Therapy (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 152
Overcoming Resistance to Natural Killer Cell Based Immunotherapies for Solid Tumors
Gaurav Nayyar, Yaya Chu, Mitchell S. Cairo
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 147
Chimeric antigen receptor-engineered natural killer cells for cancer immunotherapy
Ahmet Yılmaz, Hanwei Cui, Michael A. Caligiuri, et al.
Journal of Hematology & Oncology (2020) Vol. 13, Iss. 1
Open Access | Times Cited: 147
CAR‐NK cell in cancer immunotherapy; A promising frontier
Faroogh Marofi, Omar F. Abdul‐Rasheed, Heshu Sulaiman Rahman, et al.
Cancer Science (2021) Vol. 112, Iss. 9, pp. 3427-3436
Open Access | Times Cited: 122
NKG2D-CAR-transduced natural killer cells efficiently target multiple myeloma
Alejandra Leivas, Antonio Valeri, Laura Córdoba, et al.
Blood Cancer Journal (2021) Vol. 11, Iss. 8
Open Access | Times Cited: 104
NK cells and solid tumors: therapeutic potential and persisting obstacles
Le Tong, Carlos Jiménez‐Cortegana, Apple H.M. Tay, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 96
Challenges and new technologies in adoptive cell therapy
Pengchao Zhang, Guizhong Zhang, Xiaochun Wan
Journal of Hematology & Oncology (2023) Vol. 16, Iss. 1
Open Access | Times Cited: 82
Development of NK cell-based cancer immunotherapies through receptor engineering
Audrey Page, Nicolas Chuvin, Jenny Valladeau‐Guilemond, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 315-331
Open Access | Times Cited: 63
Targeting Natural Killer Cells for Tumor Immunotherapy
Cai Zhang, Yuan Hu, Chongdeng Shi
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 100
CAR-NK Cell: A New Paradigm in Tumor Immunotherapy
Faroogh Marofi, Alaa Sadeq Al-Awad, Heshu Sulaiman Rahman, et al.
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 87
Transforming Growth Factor-β: A Multifunctional Regulator of Cancer Immunity
Vivian Weiwen Xue, Jeff Yat‐Fai Chung, Cristina Alexandra García Córdoba, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3099-3099
Open Access | Times Cited: 85
Natural Killer Cell Interactions With Myeloid Derived Suppressor Cells in the Tumor Microenvironment and Implications for Cancer Immunotherapy
Cristina Zalfa, Silke Paust
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 71
Chimeric antigen receptor- and natural killer cell receptor-engineered innate killer cells in cancer immunotherapy
Cai Zhang, Yuan Hu, Weihua Xiao, et al.
Cellular and Molecular Immunology (2021) Vol. 18, Iss. 9, pp. 2083-2100
Open Access | Times Cited: 69
Chimeric Antigen Receptor-Engineered Natural Killer (CAR NK) Cells in Cancer Treatment; Recent Advances and Future Prospects
Reza Elahi, Amir Hossein Heidary, Kaveh Hadiloo, et al.
Stem Cell Reviews and Reports (2021) Vol. 17, Iss. 6, pp. 2081-2106
Open Access | Times Cited: 63
Overcoming tumor resistance mechanisms in CAR-NK cell therapy
Antonio Valeri, Almudena García-Ortiz, Eva Castellano, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 58
Advances in NK cell therapy for hematologic malignancies: NK source, persistence and tumor targeting.
Aimee Merino, Joseph Maakaron, Veronika Bachanová
Blood Reviews (2023) Vol. 60, pp. 101073-101073
Open Access | Times Cited: 27
Comprehensive snapshots of natural killer cells functions, signaling, molecular mechanisms and clinical utilization
Sumei Chen, Haitao Zhu, Youssef Jounaïdi
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 11
Reprogramming natural killer cells for cancer therapy
Kexin Wang, Linqin Wang, Yiyun Wang, et al.
Molecular Therapy (2024) Vol. 32, Iss. 9, pp. 2835-2855
Closed Access | Times Cited: 10
Chimeric antigen receptor–engineered natural killer and natural killer T cells for cancer immunotherapy
Dominique Bollino, Tonya J. Webb
Translational research (2017) Vol. 187, pp. 32-43
Open Access | Times Cited: 70
Natural Born Killers: NK Cells in Cancer Therapy
S. Elizabeth Franks, Benjamin Wolfson, James W. Hodge
Cancers (2020) Vol. 12, Iss. 8, pp. 2131-2131
Open Access | Times Cited: 55
The emerging role of off-the-shelf engineered natural killer cells in targeted cancer immunotherapy
Kellsye P. Fabian, James W. Hodge
Molecular Therapy — Oncolytics (2021) Vol. 23, pp. 266-276
Open Access | Times Cited: 54
Harnessing CD16-Mediated NK Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting mAbs
Cristina Capuano, Chiara Pighi, Simone Battella, et al.
Cancers (2021) Vol. 13, Iss. 10, pp. 2500-2500
Open Access | Times Cited: 53
Challenges to the broad application of allogeneic natural killer cell immunotherapy of cancer
Philippa R Kennedy, Martin Felices, Jeffrey S. Miller
Stem Cell Research & Therapy (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Plasticity of NK cells in Cancer
Dillon Corvino, Ananthi Kumar, Tobias Bald
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 29
Page 1 - Next Page

Scroll to top